Rimegepant, New Treatment for Migraines, Gets Closer to Launch

July 15, 2019

Biohaven Pharmaceuticals is celebrating a positive phase three study for a tablet called rimegepant, designed to relieve pain for those suffering from migraines. Vlad Coric, CEO of Biohaven Pharmaceuticals, discusses the development.